Calendar Nxera Pharma Co., Ltd.

Equities

4565

JP3431300007

Pharmaceuticals

Delayed Japan Exchange Other stock markets 01:30:00 2025-12-12 am EST			5-day change	1st Jan Change
864.00 ^JPY	+1.05%		+3.10%	-17.56%

Dec. 12	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
Dec. 10	Nxera Wins Bondholder Consent and Sets Terms for Buyback of 2028 Convertible Bonds	MT

Chart calendar Nxera Pharma Co., Ltd.

52aea14db978479226a1b333a2.GS2diJLB8snBdVXF5j_wWW6bg8Ie7lRGaY8-DOQVku0.VWrS8PGsk4K2PASalVmkYAPZ5I9Y3Rh1H8oNXZN3oZl7e_G524uj8ewiGA~6a0bf2ac45bc7176fd85a295340bbaa7

Upcoming events on Nxera Pharma Co., Ltd.

2026-02-16	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-05-07	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-06	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-11-05	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Nxera Pharma Co., Ltd.

2025-11-18	R&D Day
2025-11-17	Jefferies Global Healthcare Conference
2025-10-31	Q3 2025 Earnings Release
2025-08-08	Q2 2025 Earnings Release
2025-08-07	Q2 2025 Earnings Call
2025-08-05	Analyst Investor Meeting - Obesity
2025-07-01	Jefferies Global Healthcare Conference
2025-05-22	Investor Meeting
2025-05-01	Q1 2025 Earnings Release
2025-03-25	Annual General Meeting
2025-02-14	Q4 2024 Earnings Call
2025-02-14	Q4 2024 Earnings Release
2025-01-15	JP Morgan Healthcare Conference
2024-11-06	R&D Day
2024-11-01	Q3 2024 Earnings Release
2024-09-13	European Society for Medical Oncology Congress - Poster Number: 679TiP
2024-08-09	Q2 2024 Earnings Call
2024-08-09	Q2 2024 Earnings Release
2024-05-09	Q1 2024 Earnings Release
2024-03-26	Annual General Meeting

Past dividends on Nxera Pharma Co., Ltd.

2015-03-26

Bonus Payment 10 JPY

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million JPY	Released Forecast Spread	15 569 15 096 3.13%	12 766 16 328 -21.81%	28 835 32 973 -12.55%	35 263	42 456	41 096
EBITDA Million JPY	Released Forecast Spread	4 781 1 629 193.55%	-7 048 -5 290 -33.23%	-1 439 1 160 -224.06%	4 076	11 306	5 249
EBIT Million JPY	Released Forecast Spread	3 436 2 635 30.41%	-9 526 -5 364 -77.59%	-5 423 -695 -679.91%	24,0	4 758	2 966
Earnings before Tax (EBT) Million JPY	Released Forecast Spread	1 078 1 975 -45.41%	-10 680 -7 618 -40.2%	-4 662 -1 737 -168.42%	-290	6 485	2 889
Net income Million JPY	Released Forecast Spread	382 1 854 -79.4%	-7 913 -2 898 -173.08%	-4 838 -1 871 -158.53%	-223	5 020	2 284
EPS JPY	Released Forecast Spread	4,68 22,7 -79.43%	-87,2 -75,5 -15.47%	-53,9 -23,0 -134.94%	-2,48	55,8	25,5
Announcement Date		14/02/23	13/02/24	14/02/25	-

Quarterly results

Fiscal Period	June	2023 Q4	2024 Q1	2024 Q2	2024 S1	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 S1	2025 Q3	2025 Q4
Net sales Million JPY	Released Forecast Spread	7 292 13 254 -44.98%	4 611 11 300 -59.19%	8 109 8 500 -4.6%	12 720	9 263 16 600 -44.2%	6 852 12 906 -46.91%	6 644 6 467 2.74%	8 450 11 500 -26.52%	15 094 13 300 13.49%	6 754 7 000 -3.51%	17 340
EBITDA Million JPY	Released Forecast Spread		-2 093	426 1 520 -71.97%		1 802			532 1 700 -68.71%		-2 045 2 100 -197.38%
EBIT Million JPY	Released Forecast Spread	-1 534 5 148 -129.8%	-3 076 2 300 -233.74%	-578 1 520 -138.03%	-3 654	808 3 240 -75.06%	-2 577 1 335 -293.11%	-2 193 -2 833 22.6%	-563 -10 500 94.64%	-2 756 -16 500 83.3%	-3 151 0,00 -	7 110
Earnings before Tax (EBT) Million JPY	Released Forecast Spread	-2 815 1 619 -273.87%	-2 796 2 250 -224.27%	-362 1 470 -124.63%	-3 158	865 3 570 -75.77%	-2 369 1 712 -238.42%	-2 156	-1 566 700 -323.71%	-3 722	-3 116 100 -3216%	8 802
Net income Million JPY	Released Forecast Spread	-928 1 070 -186.73%	-3 281 2 950 -211.22%	-1 422 1 170 -221.54%	-4 703	1 200 -6 930 117.32%	-1 335 3 015 -144.28%	-760 -3 600 78.89%	-2 377 1 600 -248.56%	-3 137	-1 672 2 000 -183.6%	6 663
EPS JPY	Released Forecast Spread	-2,13 13,2 -116.16%	-36,7 18,9 -294.54%	-15,8 14,2 -211.64%	-52,5	13,5 -6,33 312.59%	-14,9 33,6 -144.23%	-8,45 -40,1 78.94%	-26,4 17,8 -247.89%	-34,8	-18,5 22,3 -182.96%	73,9
Announcement Date		13/02/24	09/05/24	09/08/24	09/08/24	01/11/24	14/02/25	02/05/25	08/08/25	08/08/25	31/10/25	-

Upcoming sector events for Nxera Pharma Co., Ltd.

2026-01-27	SAMSUNG BIOLOGICS CO.,LTD.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-28	BIOGEN INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-29	REGENERON PHARMACEUTICALS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-29	TWIST BIOSCIENCE CORPORATION	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-04	CONCORD BIOTECH LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-04	HUGEL, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-05	SWEDISH ORPHAN BIOVITRUM AB	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-09	CSL LIMITED	Q2 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-11	BONESUPPORT HOLDING AB	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-12	BIOGAIA AB	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Nxera Pharma Co., Ltd.

2025-12-11	ALLERGY THERAPEUTICS PLC	Q4 2025 Earnings Release
2025-12-08	EIRGENIX INC.	November 2025 Sales and Revenue Release
2025-11-14	TWIST BIOSCIENCE CORPORATION	Q4 2025 Earnings Release
2025-11-14	INHIBRX BIOSCIENCES, INC.	Q3 2025 Earnings Release
2025-11-13	ALTEOGEN INC.	Q3 2025 Earnings Release
2025-11-13	PHARMARESEARCH CO., LTD.	Q3 2025 Earnings Release
2025-11-13	NATURECELL CO.,LTD.	Q3 2025 Earnings Release
2025-11-13	CONCORD BIOTECH LIMITED	Q2 2026 Earnings Release
2025-11-12	PHARMICELL CO., LTD.	Q3 2025 Earnings Release
2025-11-12	EIRGENIX INC.	Q3 2025 Earnings Release